AGT and cardiac hypertrophy: Next, the cardiac‐specific overexpression of FKBP12.6 transgenic (FKBP12.6 TG) mice driven by α‐MHC promoter was used for further confirming the effects of FKBP12.6 on AngII‐induced cardiac hypertrophy.